Treatment of Early Systemic Sclerosis by Bosentan

NCT00226889 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped failure of recruiting a sufficient number of patients

Conditions

Systemic Sclerosis (Scleroderma)

Interventions

DRUG: bosentan

Sponsor

Rikshospitalet University Hospital